← ANALYST RATINGS · TIPRANKS
MapLight Therapeutics, Inc. (MPLT): analyst forecast and price target
Analyst consensus
Moderate Buy4 Buy2 Hold0 Sell
Ratings of 6 analysts in the last 3 months · top analysts only12-month forecast
Based on 6 price targets given in the last 3 months, the average target is $24.50, the highest $43.00, the lowest $13.00. The average is +218.2% from the last price of $7.70.
Analyst ratings 14
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| AI xAi BiotechnologyxAI Grok-4 | TipRanks - xAI | $9.00 → $8.00−11.1% | Hold | +3.9% | Reiterated | 15.10.26on TipRanks 08:06 | — | |
| AI DeepSeek BiotechnologyDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $8.50 → $8.00−5.9% | Hold | +3.9% | Reiterated | 15.10.26on TipRanks 08:06 | — | |
| AI OpenAI BiotechnologyOpenAI 5.2 | TipRanks - OpenAI | $8.50 → $8.00−5.9% | Hold | +3.9% | Reiterated | 15.10.26on TipRanks 08:06 | — | |
| AI Anthropic BiotechnologyAnthropic Opus-4.6 | TipRanks - Anthropic | $8.50 → $7.50−11.8% | Hold | −2.6% | Reiterated | 15.10.26on TipRanks 08:06 | — | |
| AI Google BiotechnologyGemini 3.1Pro | TipRanks - Google | $8.50 → $8.00−5.9% | Hold | +3.9% | Reiterated | 15.10.26on TipRanks 08:06 | — | |
| AI PerPlexity BiotechnologyPerPlexity SonarPro | TipRanks - PerPlexity | $8.50 → $7.50−11.8% | Hold | −2.6% | Reiterated | 15.10.26on TipRanks 08:06 | — | |
| AI DeepSeek BiotechnologyDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $9.00 → $8.50−5.6% | Hold | +10.4% | Reiterated | 13.10.26on TipRanks 14:05 | — | |
| AI OpenAI BiotechnologyOpenAI 5.2 | TipRanks - OpenAI | $9.00 → $8.50−5.6% | Hold | +10.4% | Reiterated | 13.10.26on TipRanks 14:05 | — | |
| AI xAi BiotechnologyxAI Grok-4 | TipRanks - xAI | $9.50 → $9.00−5.3% | Hold | +16.9% | Reiterated | 11.10.26on TipRanks 12:05 | — | |
| AI Anthropic BiotechnologyAnthropic Opus-4.6 | TipRanks - Anthropic | $9.00 → $8.50−5.6% | Hold | +10.4% | Reiterated | 11.10.26on TipRanks 12:05 | — | |
| AI Google BiotechnologyGemini 3.1Pro | TipRanks - Google | $9.00 → $8.50−5.6% | Hold | +10.4% | Reiterated | 11.10.26on TipRanks 12:05 | — | |
| AI PerPlexity BiotechnologyPerPlexity SonarPro | TipRanks - PerPlexity | $9.00 → $8.50−5.6% | Hold | +10.4% | Reiterated | 11.10.26on TipRanks 12:05 | — | |
| AI xAi BiotechnologyxAI Grok-4 | TipRanks - xAI | $10.00 → $9.50−5.0% | Hold | +23.4% | Reiterated | 09.10.26on TipRanks 13:05 | — | |
| AI DeepSeek BiotechnologyDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $10.00 → $9.00−10.0% | Hold | +16.9% | Reiterated | 09.10.26on TipRanks 13:05 | — | |
| AI OpenAI BiotechnologyOpenAI 5.2 | TipRanks - OpenAI | $9.50 → $9.00−5.3% | Hold | +16.9% | Reiterated | 09.10.26on TipRanks 13:05 | — | |
| AI Anthropic BiotechnologyAnthropic Opus-4.6 | TipRanks - Anthropic | $9.50 → $9.00−5.3% | Hold | +16.9% | Reiterated | 09.10.26on TipRanks 13:05 | — | |
| AI Google BiotechnologyGemini 3.1Pro | TipRanks - Google | $9.50 → $9.00−5.3% | Hold | +16.9% | Reiterated | 09.10.26on TipRanks 13:05 | — | |
| AI PerPlexity BiotechnologyPerPlexity SonarPro | TipRanks - PerPlexity | $9.50 → $9.00−5.3% | Hold | +16.9% | Reiterated | 09.10.26on TipRanks 13:05 | — | |
| AI OpenAI BiotechnologyOpenAI 5.2 | TipRanks - OpenAI | $10.00 → $9.50−5.0% | Hold | +23.4% | Reiterated | 07.10.26on TipRanks 13:05 | — | |
| Yatin Suneja★★★★★★★★★★#120 · hits 57% · avg +33.0% | Guggenheim | — | Hold | — | Initiated | 05.10.26on TipRanks Oct 6 05:45 | −6.2%next day +3.9% · 5 days −7.7% | ↗ |
| AI xAi BiotechnologyxAI Grok-4 | TipRanks - xAI | $13.50 → $10.00−25.9% | Hold | +29.9% | Reiterated | 03.10.26on TipRanks 13:05 | — | |
| AI DeepSeek BiotechnologyDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $13.50 → $10.00−25.9% | Hold | +29.9% | Reiterated | 03.10.26on TipRanks 13:05 | — | |
| AI OpenAI BiotechnologyOpenAI 5.2 | TipRanks - OpenAI | $13.00 → $10.00−23.1% | Hold | +29.9% | Reiterated | 03.10.26on TipRanks 13:05 | — | |
| AI Anthropic BiotechnologyAnthropic Opus-4.6 | TipRanks - Anthropic | $12.50 → $9.50−24.0% | Hold | +23.4% | Reiterated | 03.10.26on TipRanks 13:05 | — | |
| AI Google BiotechnologyGemini 3.1Pro | TipRanks - Google | $12.50 → $9.50−24.0% | Hold | +23.4% | Reiterated | 03.10.26on TipRanks 13:05 | — | |
| AI PerPlexity BiotechnologyPerPlexity SonarPro | TipRanks - PerPlexity | $13.00 → $9.50−26.9% | Hold | +23.4% | Reiterated | 03.10.26on TipRanks 13:05 | — | |
| AI xAi BiotechnologyxAI Grok-4 | TipRanks - xAI | $13.50 | Hold | +75.3% | Reiterated | 15.09.26on TipRanks 15:05 | — | |
| AI DeepSeek BiotechnologyDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $13.00 → $13.50+3.8% | Hold | +75.3% | Reiterated | 15.09.26on TipRanks 15:05 | — | |
| AI OpenAI BiotechnologyOpenAI 5.2 | TipRanks - OpenAI | $13.00 | Hold | +68.8% | Reiterated | 15.09.26on TipRanks 15:05 | — | |
| AI Anthropic BiotechnologyAnthropic Opus-4.6 | TipRanks - Anthropic | $12.50 | Hold | +62.3% | Reiterated | 15.09.26on TipRanks 15:05 | — | |
| AI Google BiotechnologyGemini 3.1Pro | TipRanks - Google | $12.50 | Hold | +62.3% | Reiterated | 15.09.26on TipRanks 15:05 | — | |
| AI PerPlexity BiotechnologyPerPlexity SonarPro | TipRanks - PerPlexity | $12.50 → $13.00+4.0% | Hold | +68.8% | Reiterated | 15.09.26on TipRanks 15:05 | — | |
| Ami Fadia★★★★★★★★★★#73 · hits 59% · avg +36.1% | Needham | $45.00 → $43.00−4.4% | Buy | +458.4% | Assigned | 31.08.26on TipRanks 07:20 | +3.2%next day +3.3% · 5 days +7.7% | ↗ |
| Sean Laaman★★★★★★★★★★#446 · hits 67% · avg +17.2% | Morgan Stanley | $21.00 | Hold | +172.7% | Assigned | 17.08.26on TipRanks 08:55 | −3.8%next day +5.8% · 5 days +2.2% | ↗ |
| Francois Brisebois★★★★★★★★★★#2595 · hits 43% · avg +5.9% | LifeSci Capital | $37.00 | Buy | +380.5% | Reiterated | 14.08.26on TipRanks 10:35 | +1.7%next day −3.8% · 5 days −3.2% | ↗ |
| Evan Seigerman★★★★★★★★★★#856 · hits 59% · avg +9.3% | BMO Capital | $46.00 → $20.00−56.5% | Buy | +159.7% | Reiterated | 13.08.26on TipRanks Aug 14 08:15 | +1.1%next day +1.7% · 5 days −1.1% | ↗ |
| Ashwani Verma★★★★★★★★★★#1305 · hits 60% · avg +13.4% | UBS | $52.00 → $13.00−75.0% | Hold | +68.8% | Downgrade | 11.08.26on TipRanks Aug 10 06:35 | +0.1%next day −1.3% · 5 days −7.6% | ↗ |
| Unknown Analyst | Jefferies | $25.00 | Buy | +224.7% | Reiterated | 30.07.26on TipRanks 13:38 | −8.3%next day −7.9% · 5 days −9.0% | ↗ |
| Adam Vogel★★★★★★★★★★#1113 · hits 79% · avg +38.0% | Craig-Hallum | $40.00 → $25.00−37.5% | Buy | +224.7% | Reiterated | 28.07.26on TipRanks 09:25 | +24.0%next day +23.6% · 5 days +1.0% | ↗ |
| Ram Selvaraju★★★★★★★★★★#212 · hits 57% · avg +24.4% | H.C. Wainwright | $45.00 → $26.00−42.2% | Buy | +237.7% | Reiterated | 28.07.26on TipRanks 06:10 | +24.0%next day +23.6% · 5 days +1.0% | ↗ |
| Sumant Kulkarni★★★★★★★★★★#670 · hits 50% · avg +14.2% | Canaccord Genuity | $43.00 → $24.00−44.2% | Buy | +211.7% | Reiterated | 27.07.26on TipRanks Jul 24 06:55 | +3.7%next day −72.9% · 5 days −65.5% | ↗ |
| Tiago Fauth★★★★★★★★★★#1228 · hits 49% · avg +13.1% | Raymond James | $46.00 | Buy | +497.4% | Initiated | 25.06.26on TipRanks Jun 24 16:35 | +4.1%next day +4.9% · 5 days +14.6% | ↗ |
| Paul Matteis★★★★★★★★★★#473 · hits 53% · avg +17.6% | Stifel Nicolaus | $28.00 → $36.00+28.6% | Buy | +367.5% | Reiterated | 02.06.26on TipRanks 06:40 | −8.3%next day +4.4% · 5 days +10.0% | ↗ |
| Joseph Thome★★★★★★★★★★#320 · hits 57% · avg +24.8% | TD Cowen | — | Buy | — | Reiterated | 14.05.26on TipRanks 17:45 | −0.7%next day −7.7% · 5 days −0.8% | ↗ |
| Marc Goodman★★★★★★★★★★#365 · hits 56% · avg +19.2% | Leerink Partners | $30.00 | Buy | +289.6% | Initiated | 21.11.25on TipRanks 08:30 | +4.3%next day −8.5% · 5 days −6.1% | ↗ |
| No ratings for this filter. | ||||||||
Every rating the collector has kept for the last 12 months, including the earlier ones of the same analyst. Latest of each analyst
Best analysts covering MapLight Therapeutics, Inc.
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $26.00 at a price of $10.19 (+155.2%); now: $26.00 at $7.70 (+237.7%).
PriceAverage targetTop analysts’ target
Recommendation trend · top analysts
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 2 | 4 | 5 | 5 | 2 |
| Buy | 7 | 12 | 15 | 9 | 4 | 0 |
| Hold | 0 | 0 | 1 | 3 | 3 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Best top-analyst consensus in the sector · General
About MapLight Therapeutics, Inc.
- CEO: Christopher A. Kroeger
- Employees: 133
- 800 Chesapeake Drive, Redwood City, CA, 94063, US
- www.maplightrx.com
MapLight Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing innovative treatments for individuals grappling with severe central nervous system (CNS) disorders. Its pipeline features several promising therapeutic candidates: ML-007C-MA, a fixed-dose combination of an M1/M4 muscarinic agonist, is being advanced to address symptoms of schizophrenia and Alzheimer's disease psychosis. Additionally, the company is investigating ML-004 for its potential to alleviate social communication deficits and irritability associated with autism spectrum disorder, while ML-021 is designed to target motor impairments seen in Parkinson's disease. Furthermore, ML-009, a G-protein-coupled receptor 52 positive allosteric modulator, is under development for conditions involving hyperactivity, impulsivity, and agitation. Beyond its drug portfolio, MapLight has also established a proprietary platform focused on identifying neural circuits fundamentally linked to disease and then precisely modulating these circuits for therapeutic benefit. Established in 2018 under its former name, Alvarado Therapeutics, Inc., the company adopted the MapLight Therapeutics, Inc. identity in August 2019. Based in Redwood City, California, it operates as a subsidiary of Catalyst4, Inc.
Data from the stock’s TipRanks forecast page, read 4 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗